NASDAQ · NA

Nano Labs Ltd.

$1.93 +$0.01 (+0.52%) 1D Market open

Key Metrics

$44.57M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow −$15.41M
Beta · 1Y 1.15
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 11
    The stock moved +23.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 11
  • May 8
    The stock moved -20.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 8
  • Apr 29
    From its Jan 29 high, the share price fell 54%.

    Peak close $3.50 on Jan 29; trough close $1.61 on Apr 29. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -54%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$44.57M
Enterprise value$64.64M
Shares outstanding23.2M
52-wk range$1.58 – $8.10
Avg volume · 20D104.6K
Net cash −$20.07M
Book value / share$4.59
ExchangeNASDAQ
About Nano Labs Ltd.
IPO dateJul 12, 2022
Employees67

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio2.09
Quick ratio2.03
Debt / equity0.24
Debt / EBITDA
Net cash −$20.07M
Working capital$31.99M

Cash Flow · TTM

Operating CF −$15.40M
Capex −$6.59K
Free cash flow −$15.41M
Buybacks $237.15K
Dividends paid
Shareholder yield 0.5%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings